Evidence map›Paper›PMID 39100457›Full record

ArticleHeliyon2024

Association between

Giovanna Isabel Ponce, Miguel Ángel Recendiz-Nuñez, César García-Torreros, Sonia Sifuentes-Franco, Moisés Enciso-Vargas, Irám Pablo Rodríguez-Sánchez, Selene Guadalupe Huerta-Olvera, Omar Graciano-Machuca

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giovanna Isabel PonceEngineering in Biological Systems, CUValles, UDG, Ameca, 46600, Jalisco, Mexico.
Miguel Ángel Recendiz-NuñezBachelor's Degree in Pharmacobiologist Chemist, La Cienega Campus (CUCiénega), UDG, Ocotlan, 47820, Jalisco, Mexico.
César García-TorrerosBachelor's Degree in Pharmacobiologist Chemist, La Cienega Campus (CUCiénega), UDG, Ocotlan, 47820, Jalisco, Mexico.
Sonia Sifuentes-FrancoClinical Science Laboratory, Department of Health Sciences, Los Valles Campus (CUValles), University of Guadalajara (UDG), Ameca, 46600, Jalisco, Mexico.
Moisés Enciso-VargasImmunity Clinic Laboratory, Toliman, 49750, Jalisco, Mexico.
Irám Pablo Rodríguez-SánchezMolecular and Structural Physiology Laboratory, School of Biological Sciences, Autonomous University of Nuevo León (UANL), San Nicolas de Los Garza, Nuevo Leon, 66455, Mexico.
Selene Guadalupe Huerta-OlveraMedical and Life Sciences Department, La Cienega Campus (CUCiénega), University of Guadalajara (UDG), Ocotlan, 47820, Jalisco, Mexico.
Omar Graciano-MachucaLaboratory of Biological Systems, Department of Health Sciences, Los Valles Campus (CUValles), University of Guadalajara (UDG), Ameca, 46600, Jalisco, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Several studies have associated members of the Objectives: To assess the association between the presence and absence Method: A systematic search was performed through the PubMed, Scopus, and Web of Science databases to obtain relevant articles published before March 2024. Associations between genes and susceptibility to IBDs were estimated by OR with 95 % CI. Results: We found positive associations of the Conclusions: Our meta-analysis indicates that individuals carrying the

Indexed as

Crohn's diseaseInflammatory bowel diseaseKiller immunoglobulin-like receptorKIRUlcerative colitis

Identifiers

PMID39100457
PMCPMC11296034

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.